MedTrace Logo

Proton Radiation for Stage II/III Breast Cancer

NCT01758445 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2025-09-04

No results posted yet for this study

Summary

The purpose of this study is to look at the rates of acute and long term adverse events of postoperative proton radiotherapy for complex loco-regional irradiation in women with loco-regionally advanced breast cancer. This study specifically includes longitudinal follow up to assess the incidence of cardiac mortality and second malignant neoplasms at 10 and 15 years following proton therapy(PT).

Conditions

  • Breast Cancer
  • Breast Neoplasm
  • Breast Tumor
  • Cancer of the Breast

Interventions

RADIATION

Proton Radiotherapy

Radiation therapy will be given once a day. Minimum of 28 treatments and may receive 6-9 additional treatments as determined by protocol \& physician.

Sponsors & Collaborators

  • Proton Collaborative Group

    lead NETWORK

Principal Investigators

  • Eugen Hug, MD · Proton Collaborative Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2027-01-31
Completion
2032-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758445 on ClinicalTrials.gov